Compare IRON & AKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | AKR |
|---|---|---|
| Founded | 2017 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | N/A | 1993 |
| Metric | IRON | AKR |
|---|---|---|
| Price | $73.40 | $20.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $108.85 | $22.00 |
| AVG Volume (30 Days) | 684.5K | ★ 1.6M |
| Earning Date | 02-26-2026 | 02-10-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | N/A | ★ 18.54 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $389,489,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.18 |
| P/E Ratio | ★ N/A | $170.50 |
| Revenue Growth | N/A | ★ 6.01 |
| 52 Week Low | $30.82 | $16.98 |
| 52 Week High | $99.50 | $24.95 |
| Indicator | IRON | AKR |
|---|---|---|
| Relative Strength Index (RSI) | 35.42 | 54.29 |
| Support Level | $76.19 | $20.54 |
| Resistance Level | $81.90 | $21.20 |
| Average True Range (ATR) | 3.43 | 0.45 |
| MACD | -0.47 | -0.01 |
| Stochastic Oscillator | 32.05 | 62.25 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.